Full agonistic properties of bay x 3702 on presynaptic and postsynaptic 5-ht1a receptors Electrophysiological Studies in the Rat Hippocampus and Dorsal Raphe

Journal of Pharmacology and Experimental Therapeutics

Volumn 286, Issue 3, 1998, Pages 1239-1247

  Donc, Jianming ^a   De Montigny, Claude ^a   Blier, Pierre ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 AMINOBUTYRIC ACID; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; POSTSYNAPTIC RECEPTOR; PRESYNAPTIC RECEPTOR; REPINOTAN; SEROTONIN 1A RECEPTOR; AUTORECEPTOR; BENZOPYRAN DERIVATIVE; SEROTONIN; SEROTONIN 1 RECEPTOR; SEROTONIN AGONIST; SEROTONIN RECEPTOR; THIAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DESENSITIZATION; DORSAL RAPHE NUCLEUS; DOWN REGULATION; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG MECHANISM; DRUG POTENCY; ELECTROPHYSIOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; RECEPTOR BLOCKING; REGULATORY MECHANISM; SEROTONIN RELEASE; SEROTONINERGIC NERVE CELL; SEROTONINERGIC TRANSMISSION; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; DRUG EFFECT; HIPPOCAMPUS; PHYSIOLOGY; RAPHE NUCLEUS; SECRETION; SPRAGUE DAWLEY RAT;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; AUTORECEPTORS; BENZOPYRANS; HIPPOCAMPUS; MALE; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN; SEROTONIN AGONISTS; THIAZOLES;

EID: 0032160077     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Aghajanian GK (1978) Feedback regulation of central monoaminergic neurons: Evidence from single-cell recording studies. Essays in Neurochemistry and Neuropharmacology, ed. by M. B. H. Youdim, W, Lovenberg, D. F. Sharman, J. R. Lagnado, pp. 1-32, Wiley, New York.
2. Blier P and de Montigny C (1983) Electrophysiological investigations on the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat. J Neurosci 3:1270-1278.
3. Blier P and de Montigny C (1987) Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: Electrophysiological studies in rat brain. Synapse 1:470-480,
4. Blier P and de Montigny C (1990) Differential effect of gepirone on presynaptic and postsynaptic serotonin receptors: Single-cell recording studies. J Clin Psychopharmacol 10(Suppl. 3):13-20.
5. Bielenberg GW and Burkhardt M (1990) 5-HT1A agonists show neuroprotectant activity in rats and mice. Eur J Pharmacol 183:1953-1954.
6. Chaput Y and de Montigny C (1988) Effects of the 5-hydroxytryptamine! receptor antagonist, BMY 7378, on 5-hydroxytryptamine! neurotransmission: Electrophysiological studies in the rat central nervous system. J Pharmarcol Exp Ther 246: 359-370.
7. Chaput Y, Blier P and de Montigny C ( 1986) In vivo electro physiological evidence for the regulatory role of auLoreceptors on serotonergic terminals. J Neurosci 6:2796 2801.
8. Ceci A, Baschirotto A and Borsini F (1994) The inhibitory effect of 8-OH-DPAT on the firing activity of dorsal raphe serotoninergic neurons in rats is attenuated by lesion of the frontal cortex. Neuropharmacology 33:709-713.
9. de Montigny C and Aghajanian GK (1977) Preferential action of 5-methoxytryptamine and 5-methoxydimethyltryptamine on presynaptic serotonin receptors: A comparative iontophoretic study with LSD and serotonin. Neuropharmacology 16:811-818.
10. de Montigny C and Aghajanian GK (1978) Tricyclic antidepressants: Long-term treatment increase responsivity of rat forebrain neurons to serotonin. Science 202:1303-1306.
11. de Montigny C, Wang RY, Reader TA and Aghajanian GK (1980) Monoaminergic denervation of the rat hippocampus: Microiontophoretic studies on pre- and postsynaptic supersensitivity to norepinephrine and serotonin. Brain Res 200: 363-376.
12. de Montigny C, Blier P and Chaput Y (1984) Electrophysiologically-identified sero tonin receptors in the rat CNS. Neuropharmacol 23:1511-1520.
13. de Montigny C 11984) Electroconvulsive shock treatments enhance responsiveness of forebrain neurons to serotonin. J Phar/narcol Exp Ther 228(l):230-234.
14. de Montigny C. Ortemann C and Blier P 11991 ) Effect of the 5-HT1A agonist
15. flesinoxan on the 5-HT system: Electrophysiological studies in the rat CNS. Soc Neurosci Abstr 17:82.1.
16. De Vry J, Glaser T, Schuurman R, Schreiber R and Traber J (1991) 5-HT1A receptors in anxiety. In: New Concepts in Anxiety, ed. by M. Briley, S. E. File, pp. 94-129, MacMillan Press, London.
17. De Vry J, Dietrich H, Glaser T, Heine HG, Horväth E, Jork R, Maertins T, Mauler P, Optiz W, Scherling D, Schohe-Loop R, SchWarz T (1997) BAY X X 3702. Drugs Future 22(4): 341-349.
18. De Vry J, Schohe-Loop R, Heine, H-G, Greuel JM, Mauler F, Schmidt B, Sommermeyer H, Glaser T (1998) Characterization of the aminomethylchroman derivative BAY X x 3702 as a highly potent 5-Hydroxytryptamine1A receptor agonist. J Pharmacol Exp Ther 284(3):1082-1087.
19. Dong J, de Montigny C and Blier P (1997) Effect of acute and repeated versus sustained administration of the 5-HT1A receptor agonist ipsapirone: electrophysiological studies in the rat hippocampus and dorsal raphe. Naunyn-Schmicdeberg'secArch Pharmacol 356:303-311.
20. El Mansari M and Blier P (1997) Effect of a prolonged paroxetine treatment on the responsiveness of postsynaptic 5-HT receptors in rat orbitofrontal cortex. Soc Neurosci Abstr 23:386.4.
21. Fanelli RJ and McMonagle-Strucko K (1992) Alteration of 5-HT1A receptor binding sites following chronic treatment with ipsapirone measured by quantitative autoradiography. Synapse 12:75-81.
22. Fletcher A, Forster EA, Bill DJ, Brown G, Cliffe IA, Hartley JE, Jones DE, Mclenachan A, Stanhope KJ, Critchley DJP, Childs KJ, Middlefell VC, Lanfumey L, Corradetti R, Laporte AM, Gozlan H, Hamon M and Dourish CT (1996) Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY100635, a potent, selective and silent 5-HT1A receptor antagonist. Behau Brain Res 73:337-353.
23. Godbout R, Chaput Y, Blier P and de Montigny C (1991) Tandospirone and its metabolite, l-(2-pyrimidinyl)-piperazine: I Effects of acute and long-term administration of tandospirone on serotonin neurotransmission. Neuropharmacol 30: 679-690.
24. Haddjeri N, Blier P and de Montigny C (1997) Antideppressant treatments enhance the tonic activation of the rat dorsal hippocampus 5-HTjA receptors. Soc Neurosci Abstr 23:385.5.
25. Hadrava V, Blier P, Dennis T, Ortemann C and de Montigny C (1995) Characterization of 5-hydroxytryptamine1A properties of flesinoxan: In vivo electrophysiology and hypothermia study. Neuropharmacology 34:1311-1326.
26. Jenkins SW, Robinson DS and Fahre LF (1990) Gepirone in the treatment of major depression. J Clin Psychopharmacol lO(suppl): 77-85.
27. Jolas T, Haj-Dahmane S, Kidd EJ, Langlois X, Lanfumey L, Fattaccini CM, Vantalon V, Laporte AM, Adrien J, Gozlan H and Hamon M (1994) Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine. J Pharmacol Exp Ther 268:1432-1443.
28. Kandel ER and Spencer WA (1961) Electrophysiology of hippocampal neurons. II. After-potentials and repetitive firing. J Neurophysiol 24:243-259.
29. Li Q, Muma NA and Van De Kar LD (1996) Chronic fluoxetine induces a gradual desensitization of 5-HT1A receptors: reductions in hypothalamic and midbrain G; and G0 proteins and in neuroendocrine responses to a 5-HT1A agonist. J Pharmacol Exp Ther 279:1035-1042.
30. Meiler E, Goldstein M and Bohmarker K (1990) Receptor reserve for 5-hydroxytryptamine1A- mediated inhibition of serotonin synthesis: Possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists. Mol Pharmacol 37:231-237.
31. Oleskevitch S and Descarries L (1990) Quantified distribution of the serotonin innervation in adult rat hippocampus. Neuroscience 34:19-33.
32. Ranck JB (1975) Behavioral correlates and firing repertoires of neurons in the dorsal hippocampal formation and septum of unrestrained rats. In: The Hippocampus. ed. by I. Isaacson, L. Robert, pp. 207-244, Plenum Press, New York.
33. Robinson DS, Rickel K and Feighner J (1990) Clinical effects of the 5-HT1A partial agonists in depression: A composite analysis of buspirone in the treatment of depression. J Clin Psychopharmacol lO(suppl): 67-76.
34. Rueter LE, de Montigny C and Blier P (1998) Electrophysiological characterization of the novel 5-HT1A agonist BIMT 17: differential efficacy at pre-vs postsynaptic areas in the rat brain. Soc Neurosci Abstr 23:435.6.
35. Schechter LE, Bolanos FJ, Gozlan H, Lanfumey L, Haj-Dahmane S, Laporte AM, Fattaccini CM and Hamon M (1990) Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: Biochemical and electrophysiological studies. J Pharmacol Exp Ther 255:1335-1347.
36. Sommermeyer H, Schreiber R, Greuel JM, De Vry J and Glaser T (1993) Anxiolytic effects of the 5-HT1A receptor agonist ipsapirone in the rat: Neurobiological correlates. Eur J Pharmacol 240:29-37.
37. Sprouse JS and Aghajanian GK (1987) Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse 1:3-9.
38. Sprouse JS and Aghajanian GK (1986) (-)-Propranolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HT1A selective agonists. Eur J Pharmacol 128:295-298.
39. Vergé D, Daval G, Patey A, Gozlan A, El Mestikawy S and Hamon M (1985) Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminial are of the 5-HT1A subtype. Eur J Pharmacol 113:463-464.
40. Wilcox CS, Ferguson JM, Dale JL and Heiser JF (1996) A double-blind trial of lowand high-dose ranges of gepirone-ER compared with placebo in the treatment of depressed outpatients. Psychopharmacol Bull 32(3): 335-342.